Fibromyalgia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing and able to give written consent to participate.
- People whose fibromyalgia meets specific scoring criteria set by the American College of Rheumatology (2016 guidelines), based on how widespread their pain is and how severe their symptoms are (confirm with trial site for exact score details).
- People who are over 18 years old (both men and women).
- People who have had their fibromyalgia formally diagnosed by a rheumatology specialist.
- People who continue to experience persistent pain despite already being on standard treatment.
- People who have not been taking the medications Daflon or Legalon for at least the past 6 months.
Who may not be able to join:
- People whose pain is caused by another condition — such as nerve pain from diabetes or shingles — that could make it difficult to measure fibromyalgia pain accurately.
- People with widespread joint or muscle pain caused by other conditions such as rheumatoid arthritis or lupus.
- People who have a known allergy to silymarin, diosmin, or hesperidin.
- People with cognitive difficulties that may affect their ability to understand the study, complete questionnaires, or follow the treatment plan.
- People who are pregnant, planning to become pregnant, or currently breastfeeding.
- People with significant other health conditions, including kidney problems, severe liver disease, chronic hepatitis C, or a history of alcohol or drug addiction.
- People with severe or currently uncontrolled major depression or anxiety disorders.
- People who are unlikely to be able to follow the medication schedule as required by the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 01064897439
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
pain assessment through Fibromyalgia impact questionnaire (FIQ)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.